close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PAVmed Inc. - Common Stock (NQ:PAVM)

2.650 -0.010 (-0.38%)
Delayed Quote Updated: 10:11 AM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PAVmed Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results
From PAVmed Inc. and Lucid Diagnostics Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis... 
Via Benzinga
News headline image
Earnings Scheduled For November 16, 2021 ↗
Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million. • Sea (... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More ↗
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at... 
Via Benzinga
News headline image
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021
From PAVmed Inc. and Lucid Diagnostics Inc.
Via Business Wire
News headline image
Veris Health Showcased in PAVmed Digital Health Virtual Investor Event
From PAVmed Inc.
Via Business Wire
News headline image
Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Galera Therapeutics (NASDAQ:GRTX... 
Via Benzinga
News headline image
PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer
From PAVmed Inc.
Via Business Wire
News headline image
ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
44 Biggest Movers From Yesterday ↗
Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. (NASDAQ: GRVI) gained 39.3% to close at $6.98 after... 
Via Benzinga
News headline image
PAVM Stock: One Big Reason Why PAVmed Is Plunging Today ↗
Today, a relatively disappointing start to trading for a PAVmed subsidiary, Lucid Diagnostics, is driving some bearish price action. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers NRX Pharmaceuticals (NASDAQ:NRXP... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Catalyst Biosciences Announces Resignation Of CFO Catalyst Biosciences, Inc... 
Via Benzinga
News headline image
Lucid Diagnostics Announces Pricing of Initial Public Offering
From PAVmed Inc.
Via Business Wire
News headline image
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage ↗
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive... 
Via Benzinga
News headline image
PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
From PAVmed Inc.
Via Business Wire
News headline image
PAVmed to Host Digital Health Virtual Investor Event
From PAVmed Inc.
Via Business Wire
News headline image
58 Biggest Movers From Yesterday ↗
Gainers MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares surged 73.4% to close at $12.80 on Thursday following news the company will buy ZACC Kabushiki Kaisha for $3.362... 
Via Benzinga
News headline image
Why PAVmed Shares Are Trading Higher Today ↗
PAVmed Inc (NASDAQ: PAVM) is trading higher Thursday after the company announced its majority-owned subsidiary, Lucid Diagnostics, filed a registration statement for a... 
Via Benzinga
News headline image
These 2 Nasdaq Small Caps Just Got Big Boosts ↗
In a rising market, these companies looked especially impressive. 
Via The Motley Fool
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers TransCode Therapeutics (NASDAQ:RNAZ) stock rose 94.3% to $5.09 during Thursday's regular session. TransCode Therapeutics's stock is trading at a volume of... 
Via Benzinga
News headline image
PAVmed's Subsidiary, Lucid Diagnostics Files For $58M IPO ↗
Lucid Diagnostic, a maker of diagnostic tests for esophageal precancer and cancer, filed to raise up to $58 million in an ... 
Via Benzinga
News headline image
38 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares jumped 101% to $14.87 following news the company will buy ZACC Kabushiki Kaisha for $3.362 million. TransCode... 
Via Benzinga
News headline image
PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
From PAVmed, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 23.66% to $3.24 during Thursday's pre-market session. The company's market cap stands at $41.8... 
Via Benzinga
News headline image
24 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC) rose 61.8% to $16.55 in pre-market trading. The company disclosed that shareholders approved the business... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.